Psychological well-being improves in women with breast cancer after treatment with applied relaxation or electro-acupuncture for vasomotor symptom.
The aim of this study was to evaluate the effect of applied relaxation and electro-acupuncture (EA) on psychological well-being in breast cancer-treated women with vasomotor symptoms. Thirty-eight breast cancer-treated postmenopausal women with vasomotor symptoms were included in the study. They were randomized to either treatment with electro-acupuncture (EA) (n = 19, three of them with tamoxifen) or applied relaxation (AR) (n = 19, five of them with tamoxifen) over a 12-week study period with six months follow-up. Vasomotor symptoms were registered daily. A visual analog scale was used to assess climacteric symptom, estimation of general well-being was made using the Symptom Checklist, and mood using the Mood Scale. These were applied during treatment and at follow-up. In total 31 women completed 12 weeks of treatment and six months of follow-up. Hot flushes were reduced by more than 50%. Climacteric symptoms significantly decreased during treatment and remained so six months after treatment in both groups. Psychological well-being significantly improved during therapy and at follow-up visits in both groups. Mood improved significantly in the electro-acupuncture treated group. In conclusion psychological well-being improved in women with breast cancer randomized to treatment with either AR or EA for vasomotor symptoms and we therefore suggest that further studies should be performed in order to evaluate and develop these alternative therapies.
Nedstrand
Elizabeth
E
Division of Obstetrics and Gynecology, Faculty of Health Sciences, Linköping University Hospital, Linköping, Sweden. elizabeth.nedstrand@lio.se
Wyon
Yvonne
Y
Hammar
Mats
M
Wijma
Klaas
K
D026881:Acupuncture / Q000295:instrumentation / Q000379:methods*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000523:psychology*; D003863:Depression / Q000209:etiology* / Q000628:therapy*; D004558:Electric Stimulation / Q000295:instrumentation; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D019584:Hot Flashes / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D008593:Menopause / Q000523:psychology; D008875:Middle Aged; D012064:Relaxation Therapy; D013629:Tamoxifen / Q000627:therapeutic use*; D014666:Vasomotor System / Q000503:physiopathology*
D004965:Estrogen Antagonists; D013629:Tamoxifen